MAXCYTE INC's ticker is and the CUSIP is 57777K106. A total of 120 filers reported holding MAXCYTE INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $71,160 | -26.0% | 18,153 | -20.9% | 0.00% | – |
| Q1 2024 | $96,211 | -2.9% | 22,962 | +8.9% | 0.00% | – |
| Q4 2023 | $99,096 | +75.3% | 21,084 | +16.4% | 0.00% | – |
| Q3 2023 | $56,535 | -31.7% | 18,120 | +0.5% | 0.00% | – |
| Q2 2023 | $82,772 | -4.2% | 18,033 | +3.4% | 0.00% | – |
| Q1 2023 | $86,368 | -19.4% | 17,448 | -11.1% | 0.00% | – |
| Q4 2022 | $107,207 | -9.1% | 19,635 | +8.2% | 0.00% | – |
| Q3 2022 | $118,000 | +42.2% | 18,150 | +2.6% | 0.00% | – |
| Q2 2022 | $83,000 | -59.3% | 17,683 | -39.3% | 0.00% | – |
| Q1 2022 | $204,000 | – | 29,138 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Blue Water Life Science Advisors, LP | 3,225,000 | $20,963,000 | 8.46% |
| NORTH RUN CAPITAL, LP | 556,960 | $3,620,000 | 7.35% |
| Vitruvian Partners LLP | 5,043,356 | $32,782,000 | 5.85% |
| Casdin Capital, LLC | 10,735,786 | $69,783,000 | 4.58% |
| RIVER GLOBAL INVESTORS LLP | 1,867,113 | $11,880,000 | 2.28% |
| APIS CAPITAL ADVISORS, LLC | 200,000 | $1,300,000 | 1.95% |
| Pier Capital, LLC | 1,262,654 | $8,207,000 | 1.41% |
| Montanaro Asset Management Ltd | 929,000 | $6,009,000 | 0.92% |
| First Light Asset Management, LLC | 1,362,543 | $8,857,000 | 0.90% |
| Grandeur Peak Global Advisors, LLC | 1,206,013 | $7,839,000 | 0.48% |